A trial of a transcranial magnetic stimulation (TMS) device developed by Neuralieve has found that it could relieve pain in migraine sufferers. Nearly 40% of patients in the trial were pain-free two hours after treatment with the device, the researchers found. This was the co-primary ...
Please Login to read the full article.
